|Articles|June 21, 2021

June 2021
Volume 27
Issue 4

Weidner et al, Appendices

Author(s)Susan Weidner, MBA, MS, Michael Diaz, MD, Cass Schaedig

Appendices to: Observations Regarding the Average Sales Price Reimbursement Methodology

eAPPENDICES Weidner et al

Articles in this issue

about 5 years ago

Article

Dollars and Sense

about 5 years ago

Article

FDA Panel Votes to Keep 4 of 6 “Dangling Approvals,” in a Sign of Things to Come

about 5 years ago

Article

Observations Regarding the Average Sales Price Reimbursement Methodology

about 5 years ago

Article

Real-World Evidence Is Key to Accelerating Oncology Approvals

about 5 years ago

Article

PATHWAYS: Oncology Care Pathways Launched by Payers: What Are the Trends?

about 5 years ago

Article

about 5 years ago

Article

A Social Worker Leads ACCC, and Her Timing Is Perfect

about 5 years ago

Article

After PD-1 Inhibitor Indications Are Withdrawn in SCLC, What Now?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Metastatic Cancer Diagnoses Drive Significantly Higher Medicaid Spending: Anuraag R. Kansal, PhD

ByBrooke McCormick,Anuraag R. Kansal, PhD

July 28th 2026

Denise Yardley, MD | Image Credit: Sarah Cannon Research Institute

Breast Cancer De-Escalation Now Rests on Molecular Profiling: Denise Yardley, MD

ByElla Hohmann, MS,Denise Yardley, MD

July 28th 2026

Denver Skyline | Image Credit: © f11photo-stock.adobe.com

Precision Therapies Are Advancing Fast, and Care Delivery Has to Catch Up

BySabrina McCrear

July 28th 2026

Vicky Keedy, MD, on AJMC branded background. | Image Credit: Vanderbilt University Medical Center

Closing Funding and Specialty Care Gaps in Soft Tissue Sarcoma: Vicki Keedy, MD

ByElla Hohmann, MS,Vicki Keedy, MD

July 28th 2026

Jeff Hunnicutt | Image provided by Navista

Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO

ByMary Caffrey

July 28th 2026

Weidner et al, Appendices

Articles in this issue

Related Content

Metastatic Cancer Diagnoses Drive Significantly Higher Medicaid Spending: Anuraag R. Kansal, PhD

Breast Cancer De-Escalation Now Rests on Molecular Profiling: Denise Yardley, MD

Precision Therapies Are Advancing Fast, and Care Delivery Has to Catch Up

Closing Funding and Specialty Care Gaps in Soft Tissue Sarcoma: Vicki Keedy, MD

Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO

Trending on AJMC

Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO

New MINT Trial Analysis Favors Liberal Transfusion After MI

Contributor: State Leaders Need Real-World Evidence to Integrate Social Care at Scale

Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhD

Semaglutide More Than Doubled Likelihood of MASH Resolution